Locotaz 250mg/31.25mg Injection
Marketer
Loco Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Locotaz 250mg/31.25mg Injection
The dual-action injection, Locotaz 250mg/31.25mg, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be strictly under medical guidance; consistent adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may compromise treatment efficacy. Potential side effects include nausea, vomiting, diarrhea, and digestive upset; worsening symptoms necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, respiratory distress) demand prompt medical care. Prior to use, disclose all current medications to your physician, including those for pre-existing conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While driving impairment is uncommon, refrain from driving if drowsiness or dizziness occurs. Optimal recovery involves adequate rest, nutritious food, and ample hydration. Your doctor may order tests to monitor the medicine's effects.
Uses of Locotaz 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Locotaz 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
Common Side effects of Locotaz 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Locotaz 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Locotaz 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Locotaz 250mg/31.25mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from using Locotaz 250mg/31.25mg Injection concurrently with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Locotaz 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; however, clinical data from human trials remain scarce.
Breast feedingCAUTION
Administration of Locotaz 250mg/31.25mg Injection necessitates careful consideration during lactation. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the maternal system.
DrivingUNSAFE
Administration of Locotaz 250mg/31.25mg Injection could induce drowsiness, blurred vision, or dizziness. Operating a vehicle is contraindicated should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Locotaz 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
For individuals with severe hepatic impairment, administering Locotaz 250mg/31.25mg Injection requires careful consideration and potential dose modification. Medical advice is necessary. Dosage alteration of Locotaz 250mg/31.25mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Locotaz 250mg/31.25mg Injection :
Should you forget a scheduled Locotaz 250mg/31.25mg Injection, seek your physician's advice.
Facts to Know About Locotaz 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently